| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $367M | — | — | — | — |
| Op. Income | $6M | — | — | — | — |
| Gross Margin | 34.6% | — | — | — | — |
| Net Margin | 2.9% | — | — | — | — |
| EPS (Diluted) | $0.12 | — | — | — | — |
| Free Cash Flow | -$11M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $367M |
| Cost of Revenue | $240M |
| GROSS PROFIT | $127M |
| R&D Expenses | $0 |
| Selling & Marketing | $86M |
| General & Administrative | $34M |
| SG&A Expenses | $120M |
| Other Expenses | $900.0K |
| Operating Expenses | $120M |
| Cost & Expenses | $360M |
| OPERATING INCOME | $6M |
| Interest Income | $0 |
| Interest Expense | $11M |
| Other Income/Expenses | $500.0K |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | -$3M |
| Net Income from Continuing Ops | $10M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $11M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $11M |
| D&A | $21M |
| EBIT | $18M |
| EBITDA | $39M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $367M |
| Cost of Revenue | $240M |
| GROSS PROFIT | $127M |
| R&D Expenses | $0 |
| Selling & Marketing | $86M |
| General & Administrative | $34M |
| SG&A Expenses | $120M |
| Other Expenses | $900.0K |
| Operating Expenses | $120M |
| Cost & Expenses | $360M |
| OPERATING INCOME | $6M |
| Interest Income | $0 |
| Interest Expense | $11M |
| Other Income/Expenses | $500.0K |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | -$3M |
| Net Income from Continuing Ops | $10M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $11M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $11M |
| D&A | $21M |
| EBIT | $18M |
| EBITDA | $39M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $11M |
| Depreciation & Amortization | $21M |
| Stock-Based Compensation | $3M |
| Deferred Income Tax | -$3M |
| Other Non-Cash Items | -$9M |
| Change in Working Capital | -$6M |
| OPERATING CASH FLOW | $16M |
| Capital Expenditure | -$27M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$31M |
| NET CASH FROM INVESTING | -$31M |
| Net Debt Issuance | $17M |
| Common Stock Repurchased | -$32.0K |
| Common Dividends Paid | -$6M |
| Other Financing Activities | -$5M |
| NET CASH FROM FINANCING | $6M |
| FREE CASH FLOW | -$11M |
| Net Change in Cash | -$8M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $55M |
| Short-Term Investments | $0 |
| Net Receivables | $166M |
| Inventory | $126M |
| Other Current Assets | $44M |
| TOTAL CURRENT ASSETS | $391M |
| PP&E (Net) | $390M |
| Goodwill | $871M |
| Intangible Assets | $983M |
| Long-Term Investments | $12M |
| Tax Assets | $0 |
| Other Non-Current Assets | $192M |
| TOTAL NON-CURRENT ASSETS | $2.4B |
| TOTAL ASSETS | $2.8B |
| Account Payables | $189M |
| Short-Term Debt | $30M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $30M |
| TOTAL CURRENT LIABILITIES | $303M |
| Long-Term Debt | $860M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $123M |
| Other Non-Current Liabilities | $29M |
| TOTAL NON-CURRENT LIABILITIES | $1.2B |
| TOTAL LIABILITIES | $1.5B |
| Common Stock | $0 |
| Additional Paid-In Capital | $1.0B |
| Retained Earnings | -$298M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $12M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $731M |
| Minority Interest | $647M |
| TOTAL EQUITY | $1.4B |
| TOTAL LIABILITIES & EQUITY | $2.8B |
| Total Debt | $1.1B |
| Net Debt | $999M |
